Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report

BACKGROUND: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Assar, Shirin, Mohammadzadeh, Dena, Norooznezhad, Amir Hossein, Payandeh, Mehrdad, Hassaninia, Daryoush, Pournazari, Mehran, Soufivand, Parviz, Yarani, Reza, Mansouri, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622869/
https://www.ncbi.nlm.nih.gov/pubmed/37928415
http://dx.doi.org/10.1016/j.rmcr.2023.101923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622869/
https://www.ncbi.nlm.nih.gov/pubmed/37928415
http://dx.doi.org/10.1016/j.rmcr.2023.101923

Ejemplares similares